Daniel Shevrin to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Daniel Shevrin has written about Antimetabolites, Antineoplastic.
Connection Strength
0.120
-
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):251-3.
Score: 0.078
-
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
Score: 0.042